Biolase (BIOL) Tops Q3 EPS by 2c

Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $11.7 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Super Micro Computer (SMCI) Falls 6%
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c
• Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14